SELLAS Life Sciences Group Inc (SLS): Any thoughts on the shelf offering, outs...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	48
Posts	7094
Boards Moderated	0
Alias Born	06/17/2009

powerwalker

Re: None

Sunday, 03/22/2026 7:08:57 AM

Sunday, March 22, 2026 7:08:57 AM

Any thoughts on the shelf offering, outside the dilution issue.

Bullish

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SLS News

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/20/2026 09:01:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:08:36 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:00:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 08:06:12 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 03:34:33 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/30/2026 09:15:04 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:35:34 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:33:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:31:37 PM
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech • GlobeNewswire Inc. • 01/08/2026 05:08:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:30:35 PM
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge • GlobeNewswire Inc. • 12/24/2025 11:00:00 AM
Sellas Life Sciences rises after reporting encouraging AML clinical results • IH Market News • 12/08/2025 03:26:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:07:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:13 PM
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (Canada) • 12/04/2025 05:20:00 PM
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (US) • 12/04/2025 05:20:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 01:45:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 09:08:16 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:01:58 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/27/2025 08:28:03 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2025 12:35:45 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent SLS News

More SLS News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent SLS News

Go Ad-Free